Riding the Waves in Uncharted Waters: Excitement and Hope for Transmasculine People in HIV Research
April 11, 2016
I cried listening to Dr. Tonia Poteat's CROI 2016 plenary presentation in February, HIV in Transgender Populations: Charted and Uncharted Waters. A few times, actually. I could barely believe -- after being left out for so long -- that transgender men were finally being recognized and highlighted as an important population for scientists to include in future HIV research.
I began a passionate quest to advocate for the inclusion of trans men in HIV prevention studies exactly one year ago at last year's CROI (one of the biggest annual HIV research conferences in the U.S.). There I learned that trans men who have sex with men (MSM) had been excluded from every clinical efficacy trial of PrEP (which is still true to date). Since that time, I have made it my mission to speak up for the inclusion of underrepresented populations in HIV research, and to do my part to overhaul the systems that have caused this, and other, scientific injustices to occur.
This year at CROI, during a plenary session to a packed auditorium, Dr. Poteat made groundbreaking strides by devoting a portion of her presentation to discuss trans men who have sex with men (MSM). She highlighted the importance of including this minority segment of the MSM population in HIV research.
This excerpt was cross-posted with the permission of BETAblog.org. Read the full article.
This article was provided by BETA. It is a part of the publication The 23rd Conference on Retroviruses and Opportunistic Infections. Visit their website at www.betablog.org.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.